Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

BAP1 increases the amount of RNApo_II. 1 / 1

| 1

➶

reach

"We found that BAP1 decreased S5-CTD binding on the SLC7A11 promoter and S2-CTD binding on exons of SLC7A11 in a DUB dependent manner (XREF_FIG and XREF_SUPPLEMENTARY) (but BAP1 did not decrease the total protein levels of RNA polymerase II, S5-CTD, or S2-CTD; XREF_SUPPLEMENTARY)."

30202049

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...